somatostatin receptor agonists (Alchemia)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namesomatostatin receptor agonists (Alchemia)
Drug Alias Nameangiogenesis inhibitors (Alchemia)ACL-16907VT-16907
ClassificationSmall molecules
Mechanisms of ActionSomatostatin receptor agonistsAngiogenesis inhibitorsGrowth hormone release inhibitors +[4] 
TargetsSomatostatin receptor
Therapy Area/IndicationsMacular DegenerationDiabetic RetinopathyNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlchemia Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlchemia Ltd
Active IndicationsN/A
Inactive IndicationsMacular DegenerationDiabetic RetinopathyNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A